Impulse control disorders and its association to medication use and other associated factors in patients with Parkinson's disease

Authors

DOI:

https://doi.org/10.31157/an.v1iInpress.652

Keywords:

parkinson's disease, risk factors, impulse control disorders

Abstract

Objectives: Impulse control disorders (ICDs) are behaviors that are performed repeatedly, to the point of interfering with the patient's functionality and daily life, without regard for their consequences and with the sole purpose of obtaining immediate gratification. ICDs have been have been related to dopaminergic treatment. This study analyzes the association of different risk factors for the development of ICD in the Mexican population.

Methods: A cross-sectional study including 244 patients diagnosed with PD was carried out. The data collected were from the year 2021 to 2023. Data were collected through structured interviews including age, gender, year of symptom onset, year of diagnosis, levodopa equivalent dose, antiparkinsonian treatment, and history of smoking and alcohol use was evaluated.

Results: 244 patients with a diagnosis of Parkinson's disease were included, of whom 146 (59.8%) were men and 98 (40.2%) women with a mean age of 63+/-12.10 years. The sample population was divided into two groups, Group 1 were patients with ICD(ICD-PD) (n=35), and Group 2 Non-ICD (n=209). ICD was associated with alcohol use 2.390 (95% CI 0.02 - 1.72).A trend was found for the use of dopamine agonists (p=0.07) No statistically significant difference was found between groups regarding smoking habits, age at diagnosis, age at symptom onset, age, diagnostic delay, and levodopa equivalent doses.

Conclusions:  Use of alcohol and agonist dopaminergic were the main associated risk factor after multivariate logistic regression.

References

Martínez-Fernández R,Gasca-Salas C, Sánchez-Ferro A, Obeso JA. Actualización en la Enfermedad de Parkinson. Revista Médica Clínica Las Condes. Volume 27, May 2016, Pages 363-379. DOI: https://doi.org/10.1016/j.rmclc.2016.06.010 DOI: https://doi.org/10.1016/j.rmclc.2016.06.010

Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, et al. Parkinson disease. Nat Rev Dis Primers. 2017 Mar 23;3:17013. Doi: 10.1038/nrdp.2017.13. DOI: https://doi.org/10.1038/nrdp.2017.13

Enrique Chávez-León , Ontiveros-Uribe MP, Carrillo-Ruiz JD. La enfermedad de Parkinson: neurología para psiquiatras. Salud Mental 2013;36:315-324. DOI: 10.17711/SM.0185-3325.2013.038 DOI: https://doi.org/10.17711/SM.0185-3325.2013.038

Daniel S, Marín M, Hans Carmona V, Melissa Ibarra Q, Manuela Gámez c. Parkinson disease: pathophysiology, diagnosis and treatment. Rev. Univ. Ind. Santander. Salud vol.50 no.1 Bucaramanga Jan./Mar. 2018. DOI: https://doi.org/10.18273/revsal.v50n1-2018008 DOI: https://doi.org/10.18273/revsal.v50n1-2018008

Berganzo K, Tijero B, González-Eizaguirre A, Somme J, Lezcano E, Gabilondo I, Fernandez M, Zarranz JJ,Gómez-Esteban JC. Motor and non-motor symptoms of Parkinson's disease and their impact on quality of life and on different clinical subgroups.

Bhat S, Rajendra Acharya U , Hagiwara Y, Dadmehr N, Adeli H. Parkinson's disease: Cause factors, measurable indicators, and early diagnosis. Comput Biol Med. 2018 Nov 1;102:234-41. Doi: 10.1016/j.compbiomed.2018.09.008. DOI: https://doi.org/10.1016/j.compbiomed.2018.09.008

H. Evans A, Okai D, Weintraub D, Shen-Yang L, S. O’Sullivan S, Voon V, Krack P, Sampaio C, Leentjens A, Martinez-Martin P, T. Stebbins G, G. Goetz C, Schrag A, MD, and the Members of the International Parkinson and Movement Disorder Society (IPMDS) Rating Scales Review Committee. Scales to Assess Impulsive and Compulsive Behaviors in Parkinson’s Disease: Critique and Recommendations. Movement Disorders, Vol. 34, No. 6, 2019. DOI: 10.1002/mds.27689 DOI: https://doi.org/10.1002/mds.27689

Pedro Vargas A, Costa Cardoso FE. Impulse control and related disorders in Parkinson’s disease. Arq. Neuro-Psiquiatr. 76 (6) • June 2018 • DOI: https://doi.org/10.1590/0004-282X20180052 DOI: https://doi.org/10.1590/0004-282x20180052

Arango Uribe GJ, Bernal Pacheco O.Trastorno de control de impulsos (TCI) en enfermedad de Parkinson. Acta Neurol Colomb. vol.35. Sept. 2019. DOI: https://doi.org/10.22379/24224022247 DOI: https://doi.org/10.22379/24224022247

López de la Hoz E. Trastorno de control de impulsos, una comorbilidad poco estudiada en la Enfermedad de Parkinson. 2023. URL: https://hdl.handle.net/2454/45649

Fernández-Prieto M, Lens M, López-Real A, Puy A, Dias-Silva JJ, Sobrido MJ. Alteraciones de la esfera emocional y el control de los impulsos en la enfermedad de Parkinson. REV NEUROL 2010;50 (Supl. 2):S41-S49. DOI: https://doi.org/10.33588/rn.50S02.2009738 DOI: https://doi.org/10.33588/rn.50S02.2009738

Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015;30:1591-601. Doi: 10.1002/mds.26424. DOI: https://doi.org/10.1002/mds.26424

Cervantes-Arriaga A, Rodríguez-Violante M, Villar-Velarde A, Corona T. Cálculo de unidades de equivalencia de levodopa en enfermedad de Parkinson. Arch Neurocien (Mex) Vol. 14, No. 2: 116-119; 2009. URL: https://www.medigraphic.com/pdfs/arcneu/ane-2009/ane092f.pdf

Martinez-Martin P, Rodriguez-Blazquez C, Alvarez-Sanchez M, Arakaki T, Bergareche-Yarza A, Chade A, et al. Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS). J Neurol. 2013 Jan;260(1):228-36. https://doi.org/10.1007/s00415-012-6624-1 DOI: https://doi.org/10.1007/s00415-012-6624-1

Weintraub D, Mamikonyan E, Papay K, A. Shea J, X. Xie S, Siderowf A. Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease–Rating Scale. Mov Disord. 2012 Feb; 27(2): 242–247. 2011.DOI: 10.1002/mds.24023 DOI: https://doi.org/10.1002/mds.24023

Ávila A, Cardona X, Bello J, Maho P, Sastre F, Martín-Baranera M. Trastornos del control de los impulsos y punding en la enfermedad de Parkinson: la necesidad de una entrevista estructurada. Elsevier. Vol. 26.. Páginas 166-172 (Abril 2011). DOI: 10.1016/j.nrl.2010.09.007 DOI: https://doi.org/10.1016/j.nrl.2010.09.007

Parra-Medina LE, Góngora-Alfaro JL. Impulse control disorders: behavioral addictions in Parkinson 's disease. Revista eNeurobiología 11(27):061020, 2020. URL:www.uv.max/e neurobiologia/vols/2020/27/27.html DOI: https://doi.org/10.25009/eb.v11i27.2558

Cervantes-Arriaga A, Rodríguez-Violante M, Yescas P, , Alonso-Vilatela E. Fluctuaciones motoras en enfermedad de Parkinson. Revista Médica del Instituto Mexicano del Seguro Social [Internet]. 2012;50(2):141-146. Recuperado de: https://www.redalyc.org/articulo.oa?id=457745494006

Weintraub D, Mamikonyan E, M.S.Impulse Control Disorders in Parkinson 's Disease. Am J Psychiatry. 2019 Jan 1;176(1):5-11. doi: 10.1176/appi.ajp.2018.18040465. DOI: https://doi.org/10.1176/appi.ajp.2018.18040465

Zhang JF, Wang XX, Feng Y, Fekete R, Jankovic J, Wu YC. Impulse Control Disorders in Parkinson's Disease: Epidemiology, Pathogenesis and Therapeutic Strategies. Front Psychiatry. 2021 Feb 9;12:635494. doi: 10.3389/fpsyt.2021.635494. DOI: https://doi.org/10.3389/fpsyt.2021.635494

Joutsa J, Martikainen K, Vahlberg T, Kaasinen V. Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson's disease. Parkinsonism Relat Disord. 2012 Dec;18(10):1079-83. doi: 10.1016/j.parkreldis.2012.06.005. DOI: https://doi.org/10.1016/j.parkreldis.2012.06.005

Weintraub D, Koester J, N. Potenza M, Impulse Control Disorders in Parkinson's Disease A Cross-Sectional Study of 3090 Patients. Arch Neurol. 2010;67(5):589-595. doi:10.1001/archneurol.2010.65 DOI: https://doi.org/10.1001/archneurol.2010.65

Steeves TD, Miyasaki J, Zurowski M, Lang AE, Pellecchia G, Van Eimeren T, Rusjan P, Houle S, Strafella AP. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain. 2009 May;132(Pt 5):1376-85. doi: 10.1093/brain/awp054 DOI: https://doi.org/10.1093/brain/awp054

Weintraub D, D. Siderowf A, N. Potenza M, Goveas J, H. Morales K, Paul J , B. Stern M. Dopamine Agonist Use is Associated with Impulse Control Disorders in Parkinson’s Disease. Arch Neurol. 2006 Jul; 63(7): 969–973. doi: 10.1001/archneur.63.7.969 DOI: https://doi.org/10.1001/archneur.63.7.969

Dongju S, M. Lacadie C, Sinha R. Neural Correlates and Connectivity Underlying Stress-Related Impulse Control Difficulties in Alcoholism. Alcoholism: clinical and experimental research. Volume 40, Issue9. September 2016. Pages 1884-1894. DOI: https://doi.org/10.1111/acer.13166 DOI: https://doi.org/10.1111/acer.13166

Theis H, Probst C, Fernagut PO. Unlucky punches: the vulnerability-stress model for the development of impulse control disorders in Parkinson’s disease. npj Parkinsons Dis. 7, 112 (2021). https://doi.org/10.1038/s41531-021-00253-z DOI: https://doi.org/10.1038/s41531-021-00253-z

Rizo C, Villaseñor-Cabrera G, Jarne-Esparcia T, Zuñiga-Ramírez A, Soto-Escageda CA. (2018). Factores de riesgo para desarrollar Trastorno del control de los impulsos en Enfermedad de Parkinson. archivos de neurociencia, Vol. 10, No. 2, 2018. URL: https://www.researchgate.net/publication/333675108_Factores_de_riesgo_para_desarrollar_Trastorno_del_control_de_los_impulsos_en_Enfermedad_de_Parkinson

H. Erga A, Alves G, Bjørn Tysnes O, Freddy Pedersen K. Impulsive and compulsive behaviors in Parkinson's disease: Impact on quality of and satisfaction with life, and caregiver burden. Parkinsonism & Related Disorders. Volume 78, September 2020, Pages 27-30. DOI: https://doi.org/10.1016/j.parkreldis.2020.07.007 DOI: https://doi.org/10.1016/j.parkreldis.2020.07.007

H. Baumann-Vogel H, Valko PO, Eisele G, Baumann CR. Impulse control disorders in Parkinson's disease: don't set your mind at rest by self-assessments. European Journal of Neurology. Volume22, Issue 4. April 2015. Pages 603-609. DOI: https://doi.org/10.1111/ene.12646 DOI: https://doi.org/10.1111/ene.12646

Biundo R, Weis L, Abbruzzese G, et al. Impulse control disorders in advanced Parkinson’s disease with dyskinesia: the ALTHEA study. Mov Disord 2017;32:1557-1565. DOI: 10.1002/mds.27181 DOI: https://doi.org/10.1002/mds.27181

Published

2023-12-24

How to Cite

Lira Juarez, L. G., Dominguez Garcia, A., Rodriguez Violante, M., Cervantes Arriaga, A., Santiago De La Cruz, E. C., Medrano Delgado, M. de los A. G., Hernandez Medrano, A. J., Regalado Mustafa, A. Y., & De La Rosa Patlan, G. E. (2023). Impulse control disorders and its association to medication use and other associated factors in patients with Parkinson’s disease. Archivos De Neurociencias, 1(Inpress). https://doi.org/10.31157/an.v1iInpress.652

Issue

Section

Original Articles